studies Archives - Sciton

Sciton Announces Excellent Outcomes From Deep Perioral Er:YAG Laser Resurfacing In Multiyear Retrospective Study

Barry — Fri, 22 Mar 2019 18:24:00 +0000

PALO ALTO, Calif, March 22, 2019 — Sciton®, a leading manufacturer of high-quality laser and light systems in the aesthetic and medical market, is announcing the long-term results of perioral rhytid correction with its Contour TRL Er:YAG laser.

“Perioral rhytids (lip lines, smoking lines) are notoriously difficult to treat”, says A. Jay Burns MD, a plastic surgeon in Dallas, TX. “Current surgical treatments for facial aging do not effectively address this condition. However, our many years of experience with the Contour TRL Er:YAG laser has shown that it is a powerful option: our specific method is safe, predictable, and effective. This was seen after a recent seven years retrospective review of all our patients who underwent perioral Erbium laser resurfacing¹.”

“As we age, lip lines and smoking lines are a reality,” remarks Aaron Burton, COO of Sciton. “Comprehensive facial rejuvenation falls short when perioral rhytids are not addressed. The Contour TRL erbium laser is extremely precise, about 12 – 14 times more than CO₂ lasers and with tissue removal control of just a few microns. This allows for superficial peels of 5 to 20 μm, and aggressive resurfacing that treats wrinkles of a depth of 800 μm and more. It provides a controlled depth of ablation with a minimal underlying thermal injury, which leads to faster recovery.”

Dr. Burns concludes, “When evaluating our series, there were zero complications at 6 months, which is much lower than our own published complication rates with the CO₂ lasers I have extensive experience with. Our excellent results are also due to the specific technique we refined over the years, including the concept of superficial islands of nonwrinkled tissue with skin appendages to aid the healing process. We had no cases of hypopigmentation and no perioral scarring. Our patients experience shorter recoveries and decreased redness with Erbium, compared to CO₂ laser treatment.”

“This is the first long-term assessment of perioral rhytids following erbium laser resurfacing and I want to congratulate Dr. Jay Burns on the excellent results achieved with his technique,” says Dr. Ludger Meyer, a plastic surgeon in Munich, Germany. “We have performed full-field erbium laser facial resurfacing for many years, including mild to aggressive perioral resurfacing. We believe the Sciton Contour TRL belongs in every plastic surgeon’s practice, as it leads to nothing short of a laser facelift and vanishing lip lines”.

¹⁾ Sanniec K, Afrooz PN, Burns AJ; Long-Term Assessment of Perioral Rhytid Correction with Erbium:YAG Laser Resurfacing; Plast Reconstr Surg. 2019 Jan;143(1): 64-74

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post Sciton Announces Excellent Outcomes From Deep Perioral Er:YAG Laser Resurfacing In Multiyear Retrospective Study appeared first on Sciton.

Sciton Announces New Multi-Center Clinical Study on HALO

Barry — Thu, 01 Nov 2018 18:28:55 +0000

PALO ALTO, Calif., November 1, 2018 — Sciton®, a leading manufacturer of high-quality laser and light systems in the medical and aesthetic market is excited to announce the publication of a new multi-center clinical study “Hybrid Fractional Laser: A Multi-Center Trial on the Safety and Efficacy for Photorejuvenation”. The paper will be published in the November issue of the Journal of Drugs in Dermatology (JDD) in a special issue for lasers, light sources, and devices. The study is authored by world-renowned physicians Jill Waibel, MD, Christopher W. Robb, MD, Elizabeth Tanzi, MD, and Jason Pozner, MD.

Link to abstract: #

This study further proves that the HALO™ Hybrid Fractional Laser offers a safe and effective treatment for a multitude of skin conditions on the face and neck while giving patients the results they desire with limited downtime.” Jill Waibel, MD Miami Dermatology and Laser Institute

“We are proud to offer our customers, patients, and business partners substantial clinical evidence that the HALO Hybrid Fractional Laser delivers high patient satisfaction, results they demand, and with the minimal downtime they expect.” Lacee J. Naik, Director of Global Marketing

About HALO Hybrid Fractional Laser
HALO, the world’s first Hybrid Fractional Laser, applies tunable non-ablative (1470nm) and ablative (2940nm) wavelengths to the same microscopic treatment zone to maximize results and reduce downtime. Sciton’s new technology produces targeted, reproducible, effective results that improve the appearance of numerous skin conditions. Intelligent energy delivery, combined with Dynamic Thermal Optimization, ensures precise, even, safe treatments. HALO owners love achieving maximum return on their investment while exceeding their patients’ expectations. Easy to use and virtually painless, HALO sets the standard for the future of laser resurfacing by providing a safe and powerful long-term hybrid solution. As part of the multifaceted, expandable JOULE platform, HALO provides the practitioner with a dynamic and essential component of their aesthetic toolbox.

The post Sciton Announces New Multi-Center Clinical Study on HALO appeared first on Sciton.

Stanford University Study Finds Evidence That Broadband Light Treatment Promotes Youthful Skin on A Molecular Level

Barry — Mon, 12 Nov 2012 21:06:37 +0000

Gene expression of aged skin more closely resembles young skin with the use of Sciton BroadBand Light treatment

PALO ALTO, Calif. — November 12, 2012 – A new study recently published in the Journal of Investigative Dermatology shows that Sciton BroadBand Light (BBL™) treatments can change the expression of genes associated with the aging process to more closely resemble young skin. The study supports the hypothesis that regulators of aging can be altered in human skin using BBL technology to provide a functional change, rather than just a cosmetic mimic of youthful appearance. BBL treatments promote the appearance of youthful skin. This study reveals that the appearance of younger skin may be due to the differences observed in gene expression patterns of aged skin becoming more like young skin. Treatments from the study were performed on the FDA-cleared Sciton Joule using the BBL module.*

Led by dermatologist Dr. Anne Lynn S. Chang of the Stanford University School of Medicine, the study (“Rejuvenation of Gene Expression Pattern of Aged Human Skin by BroadBand Light Treatment”) reveals the molecular changes that are induced by BBL, a popular treatment made by Sciton for improving the appearance of acne, sun spots, freckles, and vascular conditions. BBL treatments are requested by patients for promoting a more youthful and rejuvenated appearance. Previous studies have shown that animal models can exhibit gene expression changes to become more youthful. Dr. Chang’s study is the first to show a similar correlation in human skin treated with BBL.

“As an industry, to find a clinically sound solution for human anti-aging is critical,” said Dr. Macrene Alexiades-Armenakas, board-certified dermatologist, attending physician at Lenox Hill Hospital and Yale/New Haven VA Hospital, and Assistant Clinical Professor at Yale University School of Medicine. “As a practicing physician in the field of dermatology, it is exciting to know there is a safe, light-based treatment with groundbreaking clinical evidence supporting anti-aging and the reversal of skin damage available to our patients.”

An additional study, submitted for publication by Dr. Patrick H. Bitter, Jr. of Advanced Aesthetic Dermatology, a well-known dermatologist and co-author of the JID study, takes this groundbreaking research further and explores the practical application and patient results of BBL treatments. Dr. Bitter’s study focuses on the ability to improve the appearance of aging skin with long-term and regular interval treatments with BBL.

“The JID study is an important first step to prove that BBL treatments are a viable option for anti-aging,” said Dr. Bitter. “In my upcoming study, we provide clinical evidence on patients who have had BBL and have enjoyed younger-looking skin over the long-term. I look forward to sharing these demonstrated results with my colleagues and patients worldwide in the near future.”

“As the developer of the BBL technology, Sciton remains committed to investments not only in the equipment but in the science required to inform the development of meaningful applications for it. The BBL has an unsurpassed reputation for delivering clinically important results,” said Sciton co-founder and President, Dan Negus, Ph.D. “These basic science and clinical biomedical studies demonstrate another important validation for the dermatologic community of the sound scientific basis of the BBL technology and the results it produces.”

The study’s additional authors are Dr. Howard Y. Chang and Nicole A. Rapicavoli, both of Howard Hughes Medical Institute and Stanford University, and Dr. Kun Qu and Dr. Meihong Lin, both of Stanford University. To read the full text of the study, please visit.

About BroadBand Light (BBL) Treatment:
With its user-friendly features, superior results, and exceptional ROI, BBL™ is the most complete and versatile broadband light system in its class. Its broad range of wavelengths allow targeted treatment for many skin conditions including acne, pigmented lesions, vascular lesions and hair removal. For more information, please visit www.ForeverYoungBBL.com.

The post Stanford University Study Finds Evidence That Broadband Light Treatment Promotes Youthful Skin on A Molecular Level appeared first on Sciton.